HRSA-24-062: Ryan White HIV/AIDS Program Part C Capacity Development Program
Closed
This grant is closed. A newer notice from the same program is forecast: Ryan White HIV/AIDS Program Part C Capacity Development Program (HRSA-27-069). Status: Expected deadline March 16, 2027. It is in our archive of Health Resources and Services Administration notices from 2024.
Health Resources and Services Administration offered grants of up to $150,000 to nonprofits and tribes. It expected to make about 60 awards worth $9.0 million in total. Applications closed on April 16, 2024.
From the official notice on Grants.gov, last changed March 20, 2024. Checked November 7, 2026.
- Award ceiling$150,000
- Total funding$9.0 million
- Expected awards60
- Cost sharingNot required
- Funding typeGrant
Other notices with this title
| Notice | Posted | Deadline | Status |
|---|---|---|---|
| HRSA-27-069 | July 13, 2026 | Expected deadline March 16, 2027 | Forecast |
| HRSA-26-061 | June 5, 2026 | Closed July 8, 2026 | Closed |
| HRSA-25-049 | January 16, 2025 | Closed March 18, 2025 | Closed |
| HRSA-23-052 | December 14, 2022 | Closed February 17, 2023 | Closed |
| HRSA-22-019 | December 14, 2021 | Closed February 15, 2022 | Closed |
Key dates
| Posted | February 16, 2024 |
|---|---|
| Deadline | April 16, 2024 |
Who can apply
This opportunity was open to nonprofits and tribes.
- Native American tribal governments (Federally recognized)
- Native American tribal organizations (other than Federally recognized tribal governments)
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
You can apply if your organization is in the United States and is: Public or private, non-profit Community-based organization Tribal (governments, organizations)
Is this a realistic fit?
- Past Grants to Provide Outpatient Early Intervention Services with Respect to HIV Disease awards averaged $999,367; this notice allows up to $150,000 per award.
- No cost sharing or match is required.
What the grant funds
This notice announces the opportunity to apply for funding under the Health Resources and Services Administration’s (HRSA) Ryan White HIV/AIDS Program (RWHAP) Part C Capacity Development Program. The purpose of this program is to strengthen organizational capacity to respond to the changing health care landscape and increase access to high-quality HIV primary health care services for low-income and underserved people with HIV. Funding will support one short-term activity that can be completed by the end of the one-year period of performance. You may propose an expansion of an activity previously supported under FY 2022 or FY 2023 RWHAP Part C Capacity Development Program funding (HRSA-22-019; HRSA-23-052) or RWHAP Part D Supplemental funding (HRSA-22-037; HRSA-22-156: HRSA-23-050) for either an HIV Care Innovation or Infrastructure Development activity; however, HRSA will not fund the same activity in FY 2024 as HRSA funded previously in FY 2022 or FY 2023. If the proposed project is an expansion of a previously funded activity, you must provide a clear rationale for how the proposed activity builds upon and furthers the objectives of the previously funded HIV Care Innovation or Infrastructure Development activity. You may select only one (1) activity under the selected category.
Who has won Grants to Provide Outpatient Early Intervention Services with Respect to HIV Disease grants before
From fiscal 2021 to 2025, Grants to Provide Outpatient Early Intervention Services with Respect to HIV Disease (93.918) awarded $527 million across 527 grant awards, an average of $999,367 per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| Florida Department of Health | Florida | 10 | $10.3 million |
| Sun River Health, Inc. | New York | 2 | $4.2 million |
| Mobile County Board of Health | Alabama | 4 | $3.9 million |
| The Research Foundation for the State University of New York | New York | 2 | $3.7 million |
| Rutgers the State University of New Jersey | New Jersey | 4 | $3.7 million |
Applying now
This notice no longer takes applications. Apply under the newer notice, HRSA-27-069, which is forecast.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is HRSA-24-062 still open?
No. It closed on April 16, 2024. A newer notice is forecast: HRSA-27-069, expected deadline March 16, 2027.
Who can apply for Ryan White HIV/AIDS Program Part C Capacity Development Program?
Health Resources and Services Administration accepted applications from nonprofits and tribes. The notice adds further conditions, so read its eligibility section.
What is the deadline for Ryan White HIV/AIDS Program Part C Capacity Development Program?
Closed April 16, 2024. Applications are no longer accepted; the program's newer notices are on this page when there are any.
How much funding is available?
Awards of up to $150,000 each. About $9.0 million in total across about 60 awards.
Who has won Grants to Provide Outpatient Early Intervention Services with Respect to HIV Disease grants before?
The largest recipients over five fiscal years were Florida Department of Health, Sun River Health, Inc., Mobile County Board of Health. The program made 527 awards worth $527 million in that time.
Similar open grants
- Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)
- Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)